Leadership

Donghyun Yoon

Chief Financial Officer

Donghyun Yoon is an accomplished CFO with 14 years of experience in financial management across global and domestic life science companies. He has extensive expertise in capital markets, IPO execution, and financial process optimization. Mr. Yoon successfully spearheaded the KOSDAQ IPO process for the clinical-stage biotech ImmuneOncia and improved operating profits through advanced financial structuring at Theragen Bio. Previously at Thermo Fisher Scientific Korea, he led a $90 million M&A due diligence process, cultivating global-caliber capabilities in FP&A, treasury, and SOX compliance. His financial leadership is dedicated to aligning R&D objectives with commercialization goals through strategic budgeting, rigorous cash runway management, and robust investor relations to maximize sustainable corporate growth.